In this issue of Cell, Okin and Medzhitov report that sustained inflammation promotes hyperglycemia by targeting the mevalonate pathway. This represents an important step forward in understanding the mechanisms underlying the association between chronic low-grade inflammation and disruption of normal tissue functions in metabolic diseases.
Building on Claude Bernard's milieu inté rieur (the environment within), Walter Bradford Cannon laid the foundations for modern physiology by developing the concept of homeostasis. In his seminal 1929 paper, Cannon suggested that the ability of complex organisms to adapt to their ever-changing environments required maintaining certain physiologic parameters, such as glucose, pH, osmolality, and temperature, within a narrow range (Cannon, 1929) . Over the past century, homeostatic mechanisms regulating each of these parameters have been uncovered, and it has been established that their malfunctioning results in disease. Inflammation, which occurs during infection, injury, and tissue stress, is a major disruptor of these homeostatic control processes (Kotas and Medzhitov, 2015) . In this issue of Cell, Okin and Medzhitov set out to investigate how sustained inflammation leads to disturbances of systemic glucose homeostasis. Their results point toward an unexpected culprit (Okin and Medzhitov, 2016) (Figure 1) .
Fasting hyperglycemia is a common manifestation of obesity and type 2 diabetes, diseases associated with lowgrade chronic inflammation (Hotamisligil, 2006; Olefsky and Glass, 2010) . However, obesity is a complex multi-organ disease in which inflammation is just one of the many variables that contributes to hyperglycemia. To uncover the underlying mechanisms by which inflammation disrupts glucose homeostasis, Okin and Medzhitov developed a mouse model of sustained inflammation using lipopolysaccharide (LPS). In this model, sustained inflammation results in fasting hyperglycemia with moderate insulin resistance in the liver, a phenomenon that can be reproduced in vitro by the proinflammatory cytokine TNF-a. The inhibitory effects of TNF-a on insulin signaling in hepatocytes are not due to serine phosphorylation of insulin receptor substrate-1, as had previously been reported in muscle and adipose tissue (Gregor and Hotamisligil, 2011) . Because sustained treatment with TNF-a is required to achieve insulin resistance, the authors postulate that the mechanism underlying this effect involves changes at the transcriptional level. Consistent with this hypothesis, inhibition of NF-kB (a transcriptional regulator activated by TNF-a) is sufficient to prevent suppression of insulin signaling by TNF-a.
What might be these transcriptional changes induced by TNF-a that alter the threshold for insulin signaling in hepatocytes? RNA-seq analyses reveal that genes in the bile acid biosynthetic pathway, including the rate-limiting enzyme CYP7A1, are suppressed by TNF-a. CYP7A1 was an attractive candidate because bile acids are known to exert beneficial effects on body weight and insulin resistance by activating the nuclear receptor FXR and the cell surface receptor TGR5 (Kuipers et al., 2014) . However, the authors find no changes in the levels of bile acids or FXR activity. Since CYP7A1 mediates the degradation of cholesterol into bile acids, its suppression should result in accumulation of upstream metabolites in the mevalonate pathway. Indeed, cellular concentrations of farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), but not cholesterol, are increased under inflammatory conditions and suppressed in CYP7A1 transgenic mice. Given the role of FPP and GGPP in protein isoprenylation, these results suggest that inflammation may regulate insulin signaling by modulating isoprenylation of key proteins.
The authors triangulated on the target for isoprenylation using the following criteria: inflammation should induce the protein and it should be stabilized by isoprenylation in a FPP and GGPP concentration-dependent manner. The only gene in their dataset that met these criteria is the GTPase RHOC. RHOC is a known activator of RHO-associated protein kinase (ROCK), which has been implicated in insulin signaling. As predicted, TNF-a treatment increases phosphorylation of the ROCK target MLC2, whereas pharmacological inhibition of ROCK prevents the inhibitory effects of TNF-a on insulin signaling and glucose production. Thus, using a simple model of LPSinduced inflammation, Okin and Medzhitov uncover a new mechanism by which two transcriptional outputs of NF-kB converge to sense sustained inflammation and increase hepatic glucose production. The intrinsic delay built into this signaling motif, which is required for accumulation of GGPP and FPP, provides a mechanism by which sustained inflammation reduces insulin action in the liver.
This study provides fundamental insights into the adaptive functions of inflammation. For example, during infection, the onset of insulin resistance in liver, skeletal muscle and adipose tissue reduces nutrient storage at the expense of hyperglycemia and hyperlipidemia. While the excess mobilization of nutrients might be considered deleterious in certain settings, this likely represents an adaptive response of the host to an infectious challenge. In this case, the mobilized nutrients fuel the growth and activation of the immune system, which is necessary to combat the invading pathogen (Odegaard and Chawla, 2013) . The evolutionary primacy of this response is highlighted by its conservation across species, ranging from flies to humans.
For example, activation of Toll reduces insulin signaling and nutrient storage in flies, whereas fasting hyperglycemia and hyperlipidemia commonly accompany severe infections in humans (DiAngelo et al., 2009) . The new results from Okin and Medzhitov thus provide the mechanistic basis by which inflammation inhibits insulin signaling in the liver to prioritize nutrient availability during infection, injury, and tissue stress.
Splicing occurs co-transcriptionally, but relative rates of splicing and transcription that might reveal mechanisms of their coordinated control have remained mysterious. Now, Carrillo Oesterreich et al.
show that the fastest introns are gone nearly as soon as the 3 0 splice site is transcribed and that introns have distinct splicing kinetics with respect to polymerase progression along the gene.
Dunking a naked and fully formed premRNA into a cell extract to study spliceosome assembly and function has always been accompanied by a sense of unease. Transcription and splicing are both so rapid in vivo that the nascent transcript, born 5 0 end first from the RNA exit channel of RNA polymerase, was quietly held to be the true splicing substrate, with dynamics Lipopolysaccharide (LPS) triggers an inflammatory response that activates NF-kB signaling. NF-kB induces expression of RHOC and suppresses expression of CYP7A1, the latter causing a block in bile acid synthesis. This results in accumulation of farnesyl pyrophosphate (FPP) and geranyl geranyl pyrophosphate (GGPP), allowing for increased isoprenylation of RHOC, promoting its stability and membrane localization. RHOC subsequently activates Rho-associated protein kinase (ROCK), which acts to inhibit insulin receptor signaling by an undetermined mechanism. Reduced insulin signaling leads to increased glucose production by hepatocytes.
